Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupEndocrine and Neuroendocrine OncologyGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityDiseaseBreast CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellThyroid CancerTumor, Various OrgansTumor Biomarker DefinedSubgroupRET fusion positiveICD10C34.-C50.-C73MeSHCarcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaThyroid NeoplasmsSequenceChemotherapyChemo-substanceCisplatinHydrocortisoneSelpercatinibThiotepaChemo-substanceCisplatinHydrocortisoneSelpercatinibThiotepaChemo-substanceCisplatinHydrocortisoneSelpercatinibThiotepaChemo-substanceCisplatinHydrocortisoneSelpercatinibThiotepaNo. Substances12 RadiotherapySupportive therapySupportive substanceSupportive substanceSupportive substanceSupportive substanceNo. SubstancesProtocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentioncurativepalliativeRisksCardiotoxicityConstipationDiarrheaEmetogenicityHepatotoxicityHypertensionIncrease AminotransferasesPyrexiaQTc Time ExtensionRashThrombocytopenia below 50 000/µl only studiesPublicationAuthorDrilon AMaisch BMartinoni A Wu YDiseaseMaligner Perikarderguss, hämodynamisch relevantNichtkleinzelliges Lungenkarzinom, RET+, Stadium IB-IIIA, Erstlinie, adjuvant, ECOG 0-1RET-bedingte Tumoren, Zweitlinie oder höher, ECOG 0-2OriginCardiology Unit, Milan, ItalyDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyMemorial Sloan Kettering Cancer Center and Weill Cornell Medical College, LIBRETTO-001Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, LIBRETTO-432Protocols in Revision 4 protocols foundCisplatin 30, Tumor, Various Organs (PID2371 V1.0)Selpercatinib 160, Non-Small Cell Lung Cancer, adjuvant (PID3231 V1.0)Selpercatinib 160, Tumor Biomarker Defined (PID1732 V1.0)Thiotepa 15 / Hydrocortisone 30, Tumor, Various Organs (PID2372 V1.0)
